Lv6
2300 积分 2021-02-22 加入
Phase 1 dose escalation and expansion of AB001 in patients with metastatic castration resistant prostate cancer (mCRPC): The ARTISAN trial
3个月前
已关闭
Harmonising different approaches to patient release after radionuclide therapy: iaea safety series report no. 63: ‘Release of Patients after Radionuclide Therapy’
3个月前
已完结
ow-level determination of Th-isotopes by alpha spectrometry. Part 1: evaluation of radiochemical separation methods
4个月前
已完结
An alternative approach to efficiency tracking in thorium determination in fertilizers by alpha spectrometry
4个月前
已关闭
Regulatory Challenges in Europe and Strategies for Novel Targeted-Alpha Therapies: Academic and Industrial Perspectives
4个月前
已关闭
Experiences in quality control of astatinated compounds; focus on detecting unconjugated astatine
4个月前
已关闭
Lead radionuclides for theranostic applications in nuclear medicine: from atom to bedside
6个月前
已完结
The landscape for radioligand therapies in oncology
1年前
已完结
皖公网安备34019202002308
